Last update :
03/05/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
Valistab
Valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Cytoprotective   Mesna  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Anti Uron Poland
Mecav Mexico
Medaltec Mexico
Mescryo Mexico
Mesna Argentina, Canada, Chile, Egypt, Germany, Mexico, New Zealand, Peru, United States of America, Venezuela
Mesnex United States of America
Mesnil Mexico
Mestrian Argentina
Mexnair Colombia
Neilar Mexico
Novacarel Mexico
Uromes Ecuador, Egypt, Mexico
Uromitexan Australia, Austria, Belgium, Canada, Colombia, Ecuador, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iceland, Iran, Ireland, Italy, Luxembourg, Morocco, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Tunisia, Turkey, Venezuela
Uroprot Chile, Colombia, Venezuela
Xolem Venezuela
Stability of mixtures   Injection   Stability of mixtures : Mesna     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass Sodium chloride 0,9% 2 mg/ml
Injection   Mesna   
Injection   Granisetron hydrochloride 0,5 mg/ml
20°C-23°C
4 Hour
Light 57
Level of evidence A+
Polyvinyl chloride Water for Injection 20 mg/ml
Injection   Mesna   
Injection   Ifosfamide 20 mg/ml
37°C
7 Day
Protect from light 1408
Level of evidence A+
Polyvinyl chloride Water for Injection 20 mg/ml
Injection   Mesna   
Injection   Ifosfamide 20 mg/ml
8°C
14 Day
Protect from light 1408
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 20 mg/ml
Injection   Mesna   
Injection   Ifosfamide 20 mg/ml
20-25°C
14 Day
Light 3610
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 30 mg/ml
Injection   Mesna   
Injection   Ifosfamide 30 mg/ml
20-25°C
14 Day
Light 3610
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 10 mg/ml
Injection   Mesna   
Injection   Ifosfamide 10 mg/ml
20-25°C
14 Day
3610
Level of evidence A+
Polyvinyl chloride Sodium chloride 0,9% 0,2 & 1 mg/ml
Injection   Mesna   
Injection   Cyclophosphamide 1 mg/ml
20°C
24 Hour
Light 2104
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 1 mg/ml
Injection   Mesna   
Injection   Cyclophosphamide 5 mg/ml
20°C
24 Hour
Light 2104
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 2 & 10 mg/ml
Injection   Mesna   
Injection   Cyclophosphamide 10 mg/ml
20°C
24 Hour
Light 2104
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 2 & 10 mg/ml
Injection   Mesna   
Injection   Ifosfamide 10 mg/ml
20°C
48 Hour
Light 2104
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 1 mg/ml
Injection   Mesna   
Injection   Ifosfamide 5 mg/ml
20°C
48 Hour
Light 2104
Level of evidence D
Polyvinyl chloride Sodium chloride 0,9% 0,2 & 1 mg/ml
Injection   Mesna   
Injection   Ifosfamide 1 mg/ml
20°C
48 Hour
Light 2104
Level of evidence D
Polyethylene Glucose 5% 0,54 mg/ml
Injection   Mesna   
Injection   Cyclophosphamide 1,8 mg/ml
22°C
6 Hour
Light 1833
Level of evidence D
Polyethylene Glucose 5% 3,2 mg/ml
Injection   Mesna   
Injection   Cyclophosphamide 10,8 mg/ml
22°C
24 Hour
Light 1833
Level of evidence D
Polyethylene Glucose 5% 3,2 mg/ml
Injection   Mesna   
Injection   Cyclophosphamide 10,8 mg/ml
4°C
48 Hour
Not specified 1833
Level of evidence D
Polyethylene Glucose 5% 0,54 mg/ml
Injection   Mesna   
Injection   Cyclophosphamide 1,8 mg/ml
4°C
48 Hour
Not specified 1833
Level of evidence D
Polypropylen Syringe Sodium chloride 0,9% 40 mg/ml
Injection   Mesna   
Injection   Ifosfamide 50 mg/ml
4°C
28 Day
Protect from light 1317
Level of evidence D
  Mentions Légales